Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MetaboMiNR: a redstone MiNRcraft tool for nuclear receptors and metabolism.

Endocrinology·2026
Same author

Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females.

eLife·2025
Same author

Portal bile acid composition and microbiota along the <i>murine</i> intestinal tract exhibit sex differences in physiology.

Gut microbes·2025
Same author

Constitutive Androstane Receptor induces Ribonucleotide Reductase-M2 expression and maintains hepatocyte ploidy in mice.

bioRxiv : the preprint server for biology·2025
Same author

Surface Plasmon Resonance Based Binding Characterization for Screening RNA-Loaded Lipid Nanoparticles (LNPs): Exploring Species Cross-Reactivity in LNP-Apolipoprotein E Interactions.

Molecular pharmaceutics·2025
Same author

Diet-Induced Obesity Modulates Close-Packing of Triacylglycerols in Lipid Droplets of Adipose Tissue.

Journal of the American Chemical Society·2024
Same journal

Higher-Order Clustering of Receptors Real-Time Projected by Plasmon-ruler on the Single Live Cell.

Nano letters·2026
Same journal

Achieving Fermi-Level Depinning and Ideal Metal Contact in <i>β</i>-Ga<sub>2</sub>O<sub>3</sub> Devices via MXene Integration.

Nano letters·2026
Same journal

AI-Assisted Electron Microscopy in Structure-Performance Analysis of Advanced Catalysts: From Atomic Resolution to Statistical Significance.

Nano letters·2026
Same journal

Electrically Switchable Ultraslow Dispersionless Polaritons via Twist Engineering in van der Waals Heterostructures.

Nano letters·2026
Same journal

Correction to "Ultrasonication-Triggered Ubiquitous Assembly of Magnetic Janus Amphiphilic Nanoparticles in Cancer Theranostic Applications".

Nano letters·2026
Same journal

Tunable Proximity Valley Splitting Via Interfacial Exchange Pinning in WSe<sub>2</sub>-CrBr<sub>3</sub>-CrPS<sub>4</sub> Heterostructures.

Nano letters·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.1K

Chenodeoxycholic Acid-Loaded Nanoparticles Are Sufficient to Decrease Adipocyte Size by Inducing Mitochondrial

Weinan Zhou1, Benjamin Lew2, Hyungsoo Choi2

  • 1Department of Molecular and Integrative Physiology, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, United States.

Nano Letters
|January 26, 2024
PubMed
Summary
This summary is machine-generated.

Chenodeoxycholic acid (CDCA) nanoparticles reduce submental fat by decreasing adipocyte size and enhancing mitochondrial function. This offers a potential alternative to sodium deoxycholic acid (NaDCA) for noninvasive fat reduction.

Keywords:
Adipose tissueBile acidLocalized and sustained deliveryMitochondrial functionNanoparticle

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.1K

Related Experiment Videos

Last Updated: Jun 26, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.1K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Nanotechnology

Background:

  • Excess fat accumulation impacts health and well-being.
  • Bile acids are FDA-approved for submental fat reduction.
  • Synthetic sodium deoxycholic acid (NaDCA) has side effects like inflammation and necrosis.

Purpose of the Study:

  • Investigate chenodeoxycholic acid (CDCA) for submental fat reduction.
  • Evaluate CDCA's efficacy and safety compared to NaDCA.
  • Explore CDCA's mechanism in reducing adipocyte size.

Main Methods:

  • Developed CDCA-loaded nanoparticles for sustained delivery.
  • Injected nanoparticles into subcutaneous fat depots.
  • Monitored adipocyte size and mitochondrial respiration.

Main Results:

  • CDCA did not cause adipose cell lysis (cytolysis).
  • CDCA nanoparticles reduced adipocyte size.
  • Promoted fat burning and increased mitochondrial respiration.

Conclusions:

  • CDCA nanoparticles offer a safer alternative for submental fat reduction.
  • CDCA promotes fat reduction via enhanced mitochondrial activity, not cell lysis.
  • Highlights potential for CDCA in noninvasive cosmetic treatments.